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Aims
We investigated clinical features of newly diagnosed dia-
betes mellitus (DM) after hematopoietic stem cell trans-
plantation (HSCT) for treatment of childhood leukemia.
Methods
Between April 2009 and March 2014, total 124 patients
(73 males, 51 females) were visited the clinic of pediatric
endocrinology for routine follow-up check after HSCT
for leukemia. Among them, five patients developed DM
(4 males, 1 female). We retrospectively reviewed medical
charts including laboratory findings.
Results
Three patients were diagnosed as acute lymphoblastic
leukemia who received total body irradiation and che-
motherapy. The other two patients were diagnosed as
acute myeloblastic leukemia. The mean age at HSCT
was 8.0 ± 4.2 years. Four out of five patients developed
chronic graft-versus-host disease (GVHD) and treated
with steroid more than 2 years. The mean age at diag-
nosis of DM was 15.8 ± 1.8 years and the time interval
between HSCT and DM was 7.8 ± 4.4 years. Three
patients showed obesity depend on body mass index
(>95th percentile for sex and age). No one showed anti-
bodies related with pancreatic b-cell. All five patients
showed hyperinsulinemia with mean fasting insulin
levels at diagnosis of DM was 13.3 ± 9.2 μIU/mL. The
mean homeostasis model assessment of insulin resis-
tance index (HOMA-IR) of patients was 4.39 ± 2.01.
Conclusion
GVHD, long-term steroid treatment and insulin resis-
tance seem to be close related to develop of DM after
HSCT for treatment of childhood leukemia.
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